Reservations are full; this event will be LIVE-STREAMED.
When a lifesaving drug is discovered in the lab, it begins on a tortuous path, taking many years and costing millions of dollars, before getting to market. What takes so long, and could drugs be helping people sooner? Explore how cutting-edge biology leads to the development of novel treatments during this panel discussion featuring members of the Advanced Science Research Center (ASRC). Participants include Kevin Gardner, director of ASRC’s Structural Biology Initiative; Laura Motta-Mena, CEO of Optologix, a biomedical research company; Neil Stahl, executive vice president of research and development at Regeneron Pharmaceuticals, Inc.; and Neal Rosen, chair of the Center for Mechanism-Based Therapeutics at Memorial Sloan Kettering Cancer Center.
Presented with the Advanced Science Research Center (ASRC).